TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CCCC

C4 Therapeutics Inc

Healthcare · Biotechnology

3.40$ -0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

C4 Therapeutics Inc (CCCC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 359 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CCCC
Line item 2018 2019 2020 2021 2022 2023 2024 2025
146 118 400 507 431 376 350 359
124 97 381 326 288 271 258 258
36 91 182 76 30 127 55 75
36 91 372 309 276 254 245 249
86 4.6 4.5 5.7 1.5 12 3.1 2.4
0.0 0.0 -61
20 19 17 3.1 7.4
226 230 119 117 142 130 134 102
24 34 44 51 45 43 45 33
0.7 0.9 1.0 1.3 7.0 5.2 5.8 6.4
1.2 5.4 5.7 4.5 1.2 1.4 1.3 0.9
10 11 9.2
-80 -112 281 390 289 246 216 257
-83 -117 -184 -268 -396 -528 -634 -739
42 43 43 46 49 50 69 83

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?